MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism

BACKGROUND: Glucose metabolic reprogramming is a significant hallmark of malignant tumors including GBM. Previous studies suggest that microRNAs play key roles in modulating this process in GBM cells. miR-181b acts as a tumor suppressor miRNA in influencing glioma tumorigenesis. Our previous results...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Cell Int
Päätekijät: Yin, JianXing, Shi, ZhuMei, Wei, WenJin, Lu, Chenfei, Wei, Yutian, Yan, Wei, Li, Rui, Zhang, JunXia, You, YongPing, Wang, XieFeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Primary Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057587/
https://ncbi.nlm.nih.gov/pubmed/32158359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-1149-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia